<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01637350</url>
  </required_header>
  <id_info>
    <org_study_id>CIH-WXN-201205001</org_study_id>
    <nct_id>NCT01637350</nct_id>
  </id_info>
  <brief_title>Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes</brief_title>
  <official_title>The Effect of Blood Glucose to Different Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tianjin Medical University Cancer Institute and Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tianjin Medical University Cancer Institute and Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Different digestive tract reconstruction will affect the blood glucose level of gastric
      cancer with type 2 diabetes. Subtotal gastrectomy with Billroth II reconstruction and total
      gastrectomy with Roux-en-Y reconstruction may help to improve glycaemic control which
      includes fasting blood glucose, postprandial blood glucose, glycosylated hemoglobin, C
      -peptide and body weight of gastric cancer patients with type 2 diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Different digestive tract reconstruction will affect the blood glucose level of gastric
      cancer with type 2 diabetes. Subtotal gastrectomy with Billroth II reconstruction and total
      gastrectomy with Roux-en-Y reconstruction may help to improve glycaemic control which
      includes fasting blood glucose, postprandial blood glucose, glycosylated hemoglobin, C
      -peptide and body weight of gastric cancer patients with type 2 diabetes.

      The investigators will observed fasting blood glucose, postprandial blood glucose,
      glycosylated hemoglobin, C -peptide and body weight of the patients preoperation, 14 days
      postoperation 3 month and 6month postoperation. The investigators will observed the effect of
      blood glucose to different digestive tract reconstruction after gastrectomy of gastric cancer
      with type 2 diabetes
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Subtotal gastrectomy , BillrothⅠ</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Subtotal gastrectomy , BillrothⅡ</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>total gastrectomy, jejunal interposition</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>total gastrectomy , Roux-en-Y</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>digestive tract reconstruction</intervention_name>
    <description>Subtotal gastrectomy with BillrothⅠ or BillrothⅡ, total gastrectomy with jejunal interposition or Roux-en-Y reconstruction</description>
    <arm_group_label>Subtotal gastrectomy , BillrothⅠ</arm_group_label>
    <arm_group_label>Subtotal gastrectomy , BillrothⅡ</arm_group_label>
    <arm_group_label>total gastrectomy, jejunal interposition</arm_group_label>
    <arm_group_label>total gastrectomy , Roux-en-Y</arm_group_label>
    <other_name>no other names</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        gastric cancer with type 2 diabetes,18~75 years old,without serious underlying diseases
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18-75 years old,gastric cancer ,can be performed operation

          2. with type 2 diabetes,fasting blood glucose &gt; 6.1mmol/L

          3. without serious underlying diseases which may affect the metabolism and nutrient
             uptake

          4. without serious underlying diseases which may affect anesthesia and operation

          5. can be performed subtotal or total gastrectomy, predicted survival period &gt; 6months

          6. no other abdominal operation

          7. preoperation consultation

          8. informed consent

        Exclusion Criteria:

          1. recurrent,metastasis or die

          2. patient requests for quit

          3. pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhao Yan, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Tianjin Medical University Cancer Institute and Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tianjin Medical University Cancer Institute and Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2012</study_first_submitted>
  <study_first_submitted_qc>July 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2012</study_first_posted>
  <last_update_submitted>February 14, 2016</last_update_submitted>
  <last_update_submitted_qc>February 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

